Edgewise Therapeutics (EWTX) Treasury Shares (2020)

Edgewise Therapeutics has reported Treasury Shares for 5 years, with the latest figure at $1.3 million in Q4 2025.

• Quarterly Treasury Shares rose 99.36% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 99.36% YoY) and the FY2025 annual result came in at $1.3 million, up 99.36% from the prior year.
• Treasury Shares grew to $1.3 million in Q4 2025 per EWTX's latest filing, from $639516.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $1.3 million in Q4 2025 and troughed at $177871.0 in Q4 2023.
• A 4-year average of $589978.5 and a median of $453545.5 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares plunged 33.52% in 2023, then jumped 259.54% in 2024.
• Over 4 years, Treasury Shares stood at $267575.0 in 2022, then slumped by 33.52% to $177871.0 in 2023, then surged by 259.54% to $639516.0 in 2024, then soared by 99.36% to $1.3 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.3 million, $639516.0, and $177871.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.